Skip to main content

Coronavirus: Medical Treatments

Question for Department of Health and Social Care

UIN 35648, tabled on 19 July 2021

To ask the Secretary of State for Health and Social Care, what plans his Department has to publish bespoke clinical guidance for the treatment of people who are (a) immunocompromised or immunosuppressed and become infected with covid-19 reflecting recent innovations in the treatment of covid-19 and (b) ensure patients in this situation receive the same treatment opportunities across England.

This answer is the replacement for a previous holding answer.

Answered on

23 July 2021

Specific clinical guidance for the treatment of immunocompromised patients may be developed if research identifies effective treatments in the future. Immunocompromised patients are a priority cohort for research into therapeutic and prophylaxis treatments such as monoclonal antibody therapies, novel antivirals, and repurposed compounds.

The Department works closely with the National Health Service to ensure treatments are made available on an equitable basis.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.